Laursen, N., Sølling, A. S., Harsløf, T., & Langdahl, B. (2025). Clinical experience with denosumab discontinuation. Osteoporosis International: With other metabolic bone diseases, 36(3), 435-446. https://doi.org/10.1007/s00198-024-07351-7
Chicago-referens (17:e uppl.)Laursen, Natasha, Anne Sophie Sølling, Torben Harsløf, och Bente Langdahl. "Clinical Experience with Denosumab Discontinuation." Osteoporosis International: With Other Metabolic Bone Diseases 36, no. 3 (2025): 435-446. https://doi.org/10.1007/s00198-024-07351-7.
MLA-referens (9:e uppl.)Laursen, Natasha, et al. "Clinical Experience with Denosumab Discontinuation." Osteoporosis International: With Other Metabolic Bone Diseases, vol. 36, no. 3, 2025, pp. 435-446, https://doi.org/10.1007/s00198-024-07351-7.
